Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoffer Clemmensen

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Cell Metabolism|May 8, 2026
Harnessing PPAR pharmacology through dual incretin-directed deliveryJonas Petersen, Christoffer Clemmensen
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 24, 2023
Physiological protection against weight gain: evidence from overfeeding studies and future directionsJens Lund, Christoffer Clemmensen
Basic & Clinical Pharmacology & Toxicology|August 30, 2019
Muscarinic receptors in energy homeostasis: Physiology and pharmacologySarah Falk, Camilla Lund, Christoffer Clemmensen
Molecular and Cellular Endocrinology|July 8, 2015
Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonistsBrian Finan, Christoffer Clemmensen, Timo D Müller
Molecular Metabolism|August 15, 2022
The physiology of experimental overfeeding in animalsPablo Ranea-Robles, Jens Lund, Christoffer Clemmensen
Cell Metabolism|August 3, 2022
Outrunning obesity with Lac-Phe?Jens Lund, Christoffer Clemmensen, Thue W Schwartz
Nature Metabolism|April 10, 2025
Incretin-based therapeutics for the treatment of neurodegenerative diseasesAnika Vear, Michael T Heneka, Christoffer Clemmensen
Trends in Endocrinology and Metabolism: TEM|July 18, 2020
Role of Energy Excretion in Human Body Weight RegulationJens Lund, Zachary Gerhart-Hines, Christoffer Clemmensen
Drugs|June 28, 2019
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and OpportunitiesJonas Petersen, Kristian Strømgaard, Bente Frølund, et al.
Cell Metabolism|March 5, 2025
SnapShot: Brain-targeting anti-obesity medicationsJonas Petersen, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Cell Metabolism|May 8, 2026
Harnessing PPAR pharmacology through dual incretin-directed deliveryJonas Petersen, Christoffer Clemmensen
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 24, 2023
Physiological protection against weight gain: evidence from overfeeding studies and future directionsJens Lund, Christoffer Clemmensen
Basic & Clinical Pharmacology & Toxicology|August 30, 2019
Muscarinic receptors in energy homeostasis: Physiology and pharmacologySarah Falk, Camilla Lund, Christoffer Clemmensen
Molecular and Cellular Endocrinology|July 8, 2015
Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonistsBrian Finan, Christoffer Clemmensen, Timo D Müller
Molecular Metabolism|August 15, 2022
The physiology of experimental overfeeding in animalsPablo Ranea-Robles, Jens Lund, Christoffer Clemmensen
Cell Metabolism|August 3, 2022
Outrunning obesity with Lac-Phe?Jens Lund, Christoffer Clemmensen, Thue W Schwartz
Nature Metabolism|April 10, 2025
Incretin-based therapeutics for the treatment of neurodegenerative diseasesAnika Vear, Michael T Heneka, Christoffer Clemmensen
Trends in Endocrinology and Metabolism: TEM|July 18, 2020
Role of Energy Excretion in Human Body Weight RegulationJens Lund, Zachary Gerhart-Hines, Christoffer Clemmensen
Drugs|June 28, 2019
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and OpportunitiesJonas Petersen, Kristian Strømgaard, Bente Frølund, et al.
Cell Metabolism|March 5, 2025
SnapShot: Brain-targeting anti-obesity medicationsJonas Petersen, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen
Pageof 11